Medicines

E.U. Committee Recommends ‘Self-Amplifying’ mRNA Vaccine

The European Medicines Agency has recommended that a vaccine with "self-amplifying" mRNA be marketed.

Speaker Johnson Poised to Advance Trump Healthcare Reforms in Spending Package

House Speaker Mike Johnson (R-LA) is preparing to unveil a government spending bill that could include key components of President-elect Donald Trump’s healthcare agenda. Among the priorities under consideration is reforming Pharmacy Benefit Manager (PBM) practices, a move aimed at lowering prescription drug costs for seniors by tackling middleman-driven price inflation.

UK Government Maintains Ban on Puberty Blockers for Children Over Safety Risks

The Labour Party-led UK government announced it will uphold a ban on prescribing puberty blockers to minors, citing warnings from medical experts about “unacceptable” risks. Health Secretary Wes Streeting affirmed the decision Tuesday, emphasizing that children’s healthcare must be grounded in evidence and caution.

U.K. Places Indefinite Ban on Puberty Blockers

The United Kingdom has placed an indefinite ban on puberty blockers for minors.

CDC Recommends Expanded Bird Flu Testing

The U.S. Centers for Disease Control and Prevention (CDC) called for expanded bird flu testing after a study suggested that dairy workers showed signs of asymptomatic infection.

Appeals Court Rules Pharmaceutical Company Immune in Antitrust Case

A federal appeals court ruled that pharmaceutical company Merck is immune from allegations that it violated antitrust laws.

Moderna Offered Cash to Children Testing Booster Vaccine

Moderna has come under fire after it was discovered that the pharmaceutical company offered children cash to test a COVID-19 booster vaccine, The Telegraph reported.

WHO Developing Bird Flu mRNA Vaccine

The World Health Organization (WHO) announced a new project to advance the development of an mRNA vaccine targeting human avian influenza (H5N1).

FDA Approves Moderna’s Development of mRNA RSV Vaccine

Last week, Moderna announced that it has received approval from the Food and Drug Administration (FDA) for the development of an mRNA vaccine for respiratory syncytial virus (RSV).

Moderna Sees $1.2 Billion Loss in First Quarter

Moderna reported a $1.2 billion loss in the first quarter of 2024.

Latest news

- Advertisement -spot_img